GO
Guido Oelkers at Swedish Orphan Biovitrum (STO: SOBI)
Swedish Orphan Biovitrum is a provider of human leukocyte derived interferon and related drugs
ContactFirm
Swedish Orphan Biovitrum (STO: SOBI)
Location
Sweden
Investment Stage
Growth
Geographic Focus
SwedenEurope
About Guido Oelkers
Enriching content...
Similar Investors in Europe
Contact Swedish Orphan Biovitrum (STO: SOBI)
Get in touch for investment criteria and partnership opportunities.
Contact